The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Rhofade
oxymetazoline hydrochloride · OXYMETAZOLINE HYDROCHLORIDE 10 mg/g · Cream · Topical · Mayne Pharma
NDC 51862-0765-00 · 15 TUBE in 1 CARTON / 3 g in 1 TUBE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for oxymetazoline hydrochloride (other) in the next 90 days
sole-source market · price up 3% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- DPT Laboratories, Ltd.United Statesanalysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- NDA208552
- TE code
- AB
- Approval date
- Jan 18, 2017
- Patents / exclusivity
- 7 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 12350255 | Jun 11, 2035 |
| patent | 9974773 | Jun 11, 2035 |
| patent | 10751325 | Jun 11, 2035 |
| patent | 10335391 | Jun 11, 2035 |
| patent | 11517560 | Jun 11, 2035 |
| patent | 8883838 | Dec 1, 2031 |
| patent | 7812049 | May 2, 2028 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of oxymetazoline hydrochloride (Cream)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Mayne Pharma | OXYMETAZOLINE HYDROCHLORIDE 10 mg/g | Jul 15, 2026 | Sep 3, 2026 |
| EPI Health, LLC | OXYMETAZOLINE HYDROCHLORIDE 1 g/100g | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | OXYMETAZOLINE HYDROCHLORIDE 10 mg/g | Jul 18, 2026 | Aug 29, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Rhofade — NDC 51862-0765-00," retrieved September 3, 2026, https://drugdashboards.com/drug/51862076500.
Free to cite with attribution — see how the data is put together.